Lausanne, Switzerland – Saphetor SA today announces that it is partnering with world-leading healthcare intelligence and clinical research organization ICON to develop an innovative approach to support the planning and execution of clinical trials in the precision medicine and rare diseases space. The companies are exploring how Saphetor’s variant interpretation platform VarSome.com can be further leveraged […]
Congenica platform to continue providing tertiary analysis for Whole Genome Sequencing Cambridge, United Kingdom – Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, today announces a two-year extension to their contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in […]
DALLAS – Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome™ platform, enabling understanding of cellular diversity and disease mechanisms on a much more granular level. By unlocking single-cell sequencing data through efficient and powerful analysis, g.nome can now help researchers better understand cellular heterogeneity and gene expression. “Single-cell RNA-seq is becoming more […]
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete bibliographic coverage of the clinical exome Enhanced AI-trained phenotype driven ranking of pathogenic variants improves accuracy and efficiency of prioritizing candidate variants New features reduce time needed for prioritization, assessment and interpretation of clinically relevant variants and […]
World’s largest biomedical research resource now features more than 28 PB of data to help accelerate scientific discovery and improve human health MOUNTAIN VIEW, Calif.—DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that the DNAnexus-enabled UK Biobank Research Analysis Platform (UKB-RAP) community has grown to more than […]
Empowering Researchers with Advanced End-to-End Analysis Tools for Single-Cell and Genetic Variation Studies. We’re thrilled to announce the much-anticipated arrival of OmicsBox 3.1, a release that brings significant improvements to single-cell data analysis with UMI-based technology support and introduces a functional enrichment tool for genetic variation analysis. It also enhances OmicsBox’s long-read transcriptome analysis options, […]
Cambridge, UK – Eagle Genomics (“Eagle”) is pleased to announce it has raised additional financing of £3 million (USD $4 million) with continued participation from existing investors Environmental Technologies Fund, abrdn plc, and a consortium of investors headed by Granpool Innovative Investments, to further deploy its pioneering software platform that enables corporate customers to explore and monetize on microbiome-related […]
Espoo — Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools, announced that it has signed a new commercial partnership with ELTA 90. As part of the collaboration, ELTA 90 and Euformatics plan to locally market the complex clinical diagnostic and genomic testing tools of Euformatics, to benefit the medical […]
> Dante to utilize Amazon Bedrock to build state-of-the-art large language model (LLM) with broad genomic and clinical applications – > Amazon Bedrock will leverage Dante’s expertise with clinical interpretation and massive whole genome database – > Groundbreaking collaboration pioneering the use case for LLMs in personalized medicine, enabling extraction of phenotypes of interest to […]
Global pharmaceutical company implements Genedata Selector to automate the analysis of NGS-driven assays for adventitious agent detection during cell therapy development Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that the Astellas Institute for Regenerative Medicine (AIRM), a subsidiary of Astellas Pharma Inc. and a global pharmaceutical […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
